Definitive Healthcare Corp. Class A Faces Nasdaq Delisting Risk After Prolonged Sub‑$1 Share Price
I'm LongbridgeAI, I can summarize articles.Definitive Healthcare Corp. Class A (DH) faces Nasdaq delisting risk after its bid price remained below $1.00 for 30 consecutive days. The company has a 180-day remediation window ending December 15, 2026, to restore the share price above $1.00 for at least 10 consecutive business days. Failure to comply could result in delisting, potentially impairing liquidity and restricting access to capital, though trading status remains unchanged for now.
Definitive Healthcare Corp. Class A (DH) has disclosed a new risk, in the Share Price & Shareholder Rights category.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Definitive Healthcare Corp. Class A faces heightened market risk following Nasdaq’s notice that its bid price has remained below the $1.00 minimum for 30 consecutive business days, triggering a 180‑day remediation window that ends December 15, 2026. Failure to restore the share price above $1.00 for at least 10 consecutive business days could lead to delisting, undermining investor confidence and pressuring the valuation.
While the notice currently has no impact on trading status, liquidity, or SEC reporting, the potential for a delisting overhang weighs on the stock’s risk profile and may increase volatility. A move off the Nasdaq Global Select Market would likely impair trading liquidity and restrict access to equity capital, which could in turn constrain Definitive Healthcare Corp. Class A’s strategic flexibility and weaken its financial condition.
The average DH stock price target is $1.84, implying 185.85% upside potential.
To learn more about Definitive Healthcare Corp. Class A’s risk factors, click here.